In major causes of dementia such as Alzheimer's disease and frontotemporal lobar degeneration, abnormal proteins accumulate in the brain. This research aims to develop a comprehensive blood biomarker analysis system using brain PET imaging as a reference standard. Our goal is to enable accurate assessment of the types and levels of abnormal brain proteins through minimally invasive blood tests. This technology is expected to improve diagnostic accuracy and help predict treatment responses.